2857.6500 -22.70 (-0.79%)
NSE Apr 01, 2025 12:16 PM
Volume: 33,034
 

2857.65
-0.79%
Sharekhan
Volume growth sustains; Low input cost and efficiencies led to margin expansion: GSK Consumer reported strong results in Q4FY2019, with broad-based growth across products and channels. Revenue grew by 9%, driven by 6.3% volume growth. Business auxiliary income rose by 20% y-o-y, led by double-digit growth across all products. Unlike other FMCG companies, GSK...
Number of FII/FPI investors increased from 337 to 347 in Dec 2024 qtr.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended